Your browser doesn't support javascript.
loading
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.
Sihag, Smita; Nussenzweig, Samuel C; Walch, Henry S; Hsu, Meier; Tan, Kay See; De La Torre, Sergio; Janjigian, Yelena Y; Maron, Steven B; Ku, Geoffrey Y; Tang, Laura H; Shah, Pari M; Wu, Abraham; Jones, David R; Solit, David B; Schultz, Nikolaus; Ganesh, Karuna; Berger, Michael F; Molena, Daniela.
Afiliación
  • Sihag S; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nussenzweig SC; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Walch HS; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hsu M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tan KS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • De La Torre S; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Janjigian YY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Maron SB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ku GY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tang LH; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shah PM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wu A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jones DR; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Solit DB; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Schultz N; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ganesh K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Berger MF; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Molena D; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Cancer Res ; 28(12): 2669-2678, 2022 06 13.
Article en En | MEDLINE | ID: mdl-35377946

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article